» Articles » PMID: 20068146

ETS-1 Oncogenic Activity Mediated by Transforming Growth Factor Alpha

Overview
Journal Cancer Res
Specialty Oncology
Date 2010 Jan 14
PMID 20068146
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Inappropriate expression of Ets-1 is observed in a variety of human cancers, and its forced expression in cultured cells results in transformation, autonomous proliferation, and tumor formation. The basis by which Ets-1 confers autonomous growth, one of the primary hallmarks of cancer cells and a critical component of persistent proliferation, has yet to be fully explained. Using a variety of cancer cell lines, we show that inhibition of Ets-1 blocks tumor formation and cell proliferation in vivo and autonomous growth in culture. A screen of multiple diffusible growth factors revealed that inhibition of Ets-1 results in the specific downregulation of transforming growth factor alpha (TGFalpha), the proximal promoter region of which contains multiple ETS family DNA binding sites that can be directly bound and regulated by Ets-1. Notably, rescuing TGFalpha expression in Ets-1-silenced cells was sufficient to restore tumor cell proliferation in vivo and autonomous growth in culture. These results reveal a previously unrecognized mechanism by which Ets-1 oncogenic activity can be explained in human cancer through its ability to regulate the important cellular mitogen TGFalpha.

Citing Articles

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.

Yang Z, Liao J, Carter-Cooper B, Lapidus R, Cullen K, Dan H BMC Cancer. 2019; 19(1):485.

PMID: 31118072 PMC: 6532223. DOI: 10.1186/s12885-019-5664-7.


Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.

Rao V, Rai V, Stoupa S, Agrawal D Am J Physiol Heart Circ Physiol. 2015; 309(6):H1075-86.

PMID: 26254334 PMC: 4591361. DOI: 10.1152/ajpheart.00378.2015.


PAX3 and ETS1 synergistically activate MET expression in melanoma cells.

Kubic J, Little E, Lui J, Iizuka T, Lang D Oncogene. 2014; 34(38):4964-74.

PMID: 25531327 PMC: 4476961. DOI: 10.1038/onc.2014.420.


Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells.

Li C, Wang Z, Chen Y, Zhou M, Zhang H, Chen R Oncol Rep. 2014; 33(2):559-65.

PMID: 25421630 PMC: 4306275. DOI: 10.3892/or.2014.3613.


Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.

Li P, Yang R, Gao W Mol Cancer. 2014; 13:55.

PMID: 24618337 PMC: 3975176. DOI: 10.1186/1476-4598-13-55.